Department of Microbiology and Immunology, Emory University, Atlanta, GA 30322, USA.
Immunol Res. 2011 May;50(1):39-48. doi: 10.1007/s12026-011-8204-3.
T cell recognition of antigen is a crucial aspect of the adaptive immune response. One of the most common means of pathogen immune evasion is mutation of T cell epitopes. T cell recognition of such ligands can result in a variety of outcomes including activation, apoptosis and anergy. The ability of a given T cell to respond to a specific peptide-MHC ligand is regulated by a number of factors, including the affinity, on- and off-rates and half-life of the TCR-peptide-MHC interaction. Interaction of T cells with low-potency ligands results in unique signaling patterns and requires engagement with a larger number of T cell receptors than agonist ligands. This review will address these aspects of T cell interaction with weak ligands and the ways in which these ligands have been utilized therapeutically.
T 细胞识别抗原是适应性免疫反应的关键方面。病原体免疫逃避的最常见手段之一是 T 细胞表位的突变。T 细胞对这种配体的识别可能导致多种结果,包括激活、凋亡和无能。给定 T 细胞对特定肽-MHC 配体的反应能力受许多因素的调节,包括 TCR-肽-MHC 相互作用的亲和力、结合和解离速率以及半衰期。T 细胞与低效力配体的相互作用导致独特的信号模式,并且需要与比激动剂配体更多的 T 细胞受体结合。这篇综述将讨论 T 细胞与弱配体相互作用的这些方面,以及这些配体在治疗中的应用方式。